Basis Science, maker of the Basis wristband for collecting personal health data, extends series B financing by $11.75m to $23m, with investments from Intel Capital, Stanford University and others.

Cambridge University spin-out Owlsense to form its own medtech startup.

Orphan drug accelerator has now raised $26m from investors including Lundbeckfond Ventures and Pfizer, to help create companies focused on rare diseases.

Celgene Corporation commits $35m to biopharmaceutical company PharmAkea in strategic alliance to develop therapeutics for cancer and fibrosis.

US-based startup BioNano raises $10m to continue commercialisation of gene sequencing technology.

The Advisory Board Company and UPMC Health Plan back $100m series B funding for their value-based care delivery company Evolent.